Safety of abacavir therapy after temporary interruptions in patients without hypersensitivity reactions to the drug

AIDS. 2002 Jun 14;16(9):1299-301. doi: 10.1097/00002030-200206140-00018.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Dideoxynucleosides / administration & dosage*
  • Dideoxynucleosides / adverse effects*
  • Dideoxynucleosides / therapeutic use
  • Drug Hypersensitivity
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Male

Substances

  • Dideoxynucleosides
  • abacavir